醫藥和生物技術領域的共同開發契約（2016-2026 年）

醫藥和生物技術領域的共同開發契約（2016-2026 年）

本文將幫助您了解製藥和生技公司如何透過合作開發夥伴關係分擔開發責任、投資、風險和商業性機會。

《醫藥和生物技術領域的共同開發契約（2016-2026）》提供了醫藥和生物技術行業宣布的 1,069 項共同開發契約的全面資訊。

本報告探討了各公司如何合作推動資產和技術進入開發階段，同時整合各自的專業知識、資源和能力，並在合作夥伴之間檢驗開發責任、成本、權利和未來的商業性機會。

這份報告不只是簡單地列出交易；它幫助用戶了解哪些公司正在建立聯合開發夥伴關係，它們的活動集中在哪些地區，協議是如何構建的，以及可以從披露的財務條款和公開的合約文件中了解到什麼。

本報告為參與評估、建立和談判聯合開發夥伴關係關係的業務發展、許可、公司策略、研發策略、合作夥伴關係管理和法律團隊提供可操作的資訊來源和基準資源。

了解共同開發契約的整體情況。

本報告分析了2016年至2026年的合作發展活動，內容包括：

• 共同開發契約結論的年度趨勢
• 合作關係發展階段
• 產業部門
• 治療區域
• 技術類型
• 積極簽訂共同開發契約的公司
• 根據已揭露的交易金額，主要交易金額
• 建立聯合開發夥伴關係的策略性原因
• 共同開發契約的趨勢
• 這樣一來，使用者就能看到合作開發活動集中在哪些領域，哪些公司最活躍，以及合作開發策略在不同技術、治療領域和開發階段有何不同。
• 了解共同開發契約的結構
• 在聯合發展夥伴關係中，相關各方需要決定如何分配發展活動、資金籌措、決策權、智慧財產權和未來權利。

本報告提供以下信息，幫助使用者檢驗以下方面：

• 發展責任
• 研發經費
• 成本分攤安排
• 智慧財產權所有權和權利
• 管治與決策
• 發展里程碑
• 監管責任
• 商業化權利
• 與該地區和市場相關的權利
• 製造和供應方面的職責
• 已揭露的財務狀況
• 合約期限和終止條款
• 對於正在考慮聯合開發框架和準備合作談判的團隊來說，這將是一個有用的參考資料。
• 對標關鍵交易和財務狀況
• 本報告根據已揭露的交易價值確定了重點聯合開發項目，並提供了與每份合約相關的可用財務資訊。
• 用戶可以查看交易總額、預付款、里程碑結構、股票補償組成以及其他已揭露的經濟條款（如有）。
• 這樣可以將提案的交易置於類似實際交易的背景下，從而支持基於證據的交易準備和基準測試。
• 確定共同開發項目的關鍵交易商。
• 該報告重點介紹了在合作開發領域最活躍的 25 位頂級交易商，並深入分析了最常利用合作開發夥伴關係關係的公司。

了解哪些人在積極簽訂這類契約，對以下幾個方面很有幫助：

• 尋找合作夥伴
• 競爭對手分析
• 調查與評估
• 業務發展策略
• 夥伴關係活動評估
• 單一交易歷史記錄允許用戶調查特定公司如何在多個交易中參與協作開發。
• 從實際合約文件中學習
• 本報告提供了公開可取得的與共同開發相關的合約文件。
• 這些協議提供了僅憑公司新聞稿無法獲得的詳細信息，揭示了每個選定的合作夥伴如何處理開發義務、管治、知識產權、成本分攤、商業化權利、里程碑、終止和其他可協商事項。
• 對於正在準備或談判共同開發契約的團隊來說，這些真實案例提供了寶貴的見解，讓他們了解類似的交易是如何實際記錄下來的。
• 綜合聯合開發專案目錄
• 本報告包含 1,069 個聯合開發項目的綜合目錄，使用戶能夠找到與其自身資產、技術和合作目標相關的交易。

在以下條件下可以查看交易記錄：

• 公司
• 治療區域
• 技術類型
• 合約揭露狀態
• 每筆交易都與其底層交易記錄相關聯，從而可以存取詳細的交易資訊和相關的合約文件（如有）。
• 誰該使用這份報告？
• 業務拓展與授權團隊
• 在準備進行聯合開發討論時，我們會確定相關的領先交易、潛在合作夥伴和交易結構。
• 研究與開發及投資組合策略團隊
• 這使我們能夠了解每家公司如何透過夥伴關係分擔開發責任、能力和投資。
• 企業策略團隊
• 我們追蹤合作開發的發展趨勢，了解競爭對手和潛在合作夥伴如何參與外部創新。
• 聯盟管理團隊
• 我們將檢驗類似協議中開發責任、管治和持續合作夥伴義務的結構。
• 法律及交易團隊
• 為了協助合約的起草和談判，我們將仔細審查交易結構和公開的合約條款。
• 競爭情報與市場調查團隊
• 我們按公司、發展階段、治療領域和技術分析交易趨勢，以確定重要的合作趨勢。
• 我們將整體市場資訊轉化為針對每家公司的具體洞察。
• 對於符合資格的客戶，Current Partnering 不僅會提供報告，還會為高階主管提供客製化的合作關係簡報。
• 本簡報將說明如何將基礎交易資訊應用於您自己的業務、資產、技術或合作目標。
• 如有需要，我們可以提供相關的類似交易、有潛力的合作夥伴候選人、競爭對手的活動、開發階段的基準、交易結構、財務基準、合約見解以及其他專門為您挑選的情報。
• 請索取樣本或聯絡 Current Partnering 討論報告內容以及我們是否可以為貴公司提供客製化分析。

目錄

執行摘要

第1章：引言

第2章：聯合開發交易的趨勢

• 介紹
• 共同開發契約的定義
• 共同開發契約的趨勢
• 簽訂聯合發展夥伴關係協議的理由
• 共同開發契約的未來

第3章：共同開發契約結構概述

• 介紹
• 共同開發契約的結構

第4章：主導共同開發契約

• 介紹
• 按以金額為準的前幾大聯合開發項目

第5章：積極參與聯合開發專案的25家頂尖公司

• 介紹
• 參與聯合開發案最積極的25家公司

第6章：共同開發契約（包括協議清單）

• 介紹
• 聯合開發涉及合約。
• 特價優惠列表
• 交易目錄 - 公司特定聯合開發交易 AZ
• 交易目錄 - 按治療領域分類的合作開發交易
• 交易目錄 - 按技術領域分類的合作開發交易
• 關於 Biopharma Research Ltd.
• Current Partnering
• 目前合約
• 最新報告標題

Co-development Deals in Pharmaceuticals and Biotechnology 2016-2026

Understand how pharmaceutical and biotechnology companies share development responsibilities, investment, risk and commercial opportunity through co-development partnerships.

Co-development Deals in Pharmaceuticals and Biotechnology 2016-2026 provides comprehensive intelligence on 1,069 co-development deals announced across the pharmaceutical and biotechnology sectors.

The report examines how companies collaborate to advance assets and technologies through development, combining expertise, resources and capabilities while allocating development responsibilities, costs, rights and future commercial opportunities between partners.

Rather than simply identifying transactions, the report enables users to understand who is entering co-development partnerships, where activity is concentrated, how agreements are structured, and what can be learned from disclosed financial terms and publicly available contract documents.

It provides a practical intelligence and benchmarking resource for business development, licensing, corporate strategy, R&D strategy, alliance management and legal teams involved in evaluating, structuring or negotiating collaborative development partnerships.

Understand the co-development deal landscape

The report analyzes co-development activity from 2016 to 2026, including:

• Trends in co-development dealmaking by year
• Stage of development at the time of partnering
• Industry sector
• Therapy area
• Technology type
• Most active co-development dealmakers
• Leading deals by disclosed value
• Strategic reasons for entering co-development partnerships
• How co-development dealmaking is evolving
• This enables users to see where collaborative development activity is concentrated, which companies are most active and how co-development strategies differ across technologies, therapeutic areas and stages of development.
• Understand how co-development agreements are structured
• Co-development partnerships require the parties to determine how development activity, funding, decision-making, intellectual property and future rights will be allocated.

The report provides intelligence to help users examine areas including:

• Development responsibilities
• Research and development funding
• Cost-sharing arrangements
• Intellectual property ownership and rights
• Governance and decision-making
• Development milestones
• Regulatory responsibilities
• Commercialization rights
• Geographic and market rights
• Manufacturing and supply responsibilities
• Financial terms where disclosed
• Term and termination provisions
• This provides useful reference points for teams assessing potential co-development structures and preparing for partnering discussions.
• Benchmark leading deals and financial terms
• The report identifies leading co-development transactions by disclosed deal value and provides access to available financial information associated with individual agreements.
• Users can investigate headline deal values, upfront payments, milestone structures, equity components and other disclosed economics where available.
• This helps place proposed transactions into the context of comparable real-world deals and supports evidence-based deal preparation and benchmarking.
• Identify leading co-development dealmakers
• The report profiles the Top 25 most active co-development dealmakers, providing insight into the companies most frequently using collaborative development partnerships.

Understanding who is actively entering these agreements can support:

• Partner identification
• Competitor analysis
• Search and evaluation
• Business development strategy
• Assessment of partnering behaviour
• Individual deal histories allow users to investigate how specific companies have approached co-development across multiple transactions.
• Learn from real-world contract documents
• Where publicly available, the report provides access to underlying co-development contract documents.
• These agreements provide greater detail than company announcements alone and can reveal how selected partners have addressed development obligations, governance, intellectual property, cost allocation, commercialization rights, milestones, termination and other negotiated provisions.
• For teams preparing for or negotiating a co-development agreement, these real-world examples provide valuable insight into how comparable transactions have been documented in practice.
• Comprehensive co-development deal directory
• The report includes a comprehensive directory of 1,069 co-development deals, allowing users to identify transactions relevant to their own assets, technologies and partnering objectives.

Deals can be reviewed by:

• Company
• Therapy area
• Technology type
• Contract availability
• Individual transactions are linked to their underlying deal records, providing a route to further deal information and associated contract documentation where available.
• Who should use this report?
• Business Development and Licensing teams
• Identify relevant precedent transactions, potential partners and deal structures when preparing for co-development discussions.
• R&D and Portfolio Strategy teams
• Understand how companies are using partnerships to share development responsibilities, capabilities and investment.
• Corporate Strategy teams
• Track collaborative development activity and understand how competitors and potential partners are approaching external innovation.
• Alliance Management teams
• Examine how development responsibilities, governance and ongoing partner obligations have been structured in comparable agreements.
• Legal and Transaction teams
• Review deal structures and publicly available contract language to support agreement preparation and negotiation.
• Competitive and Market Intelligence teams
• Analyze deal activity by company, development stage, therapy area and technology to identify important partnering trends.
• Turn market-wide intelligence into company-specific insight
• For qualifying customers, Current Partnering can also provide a Customized Executive Partnering Briefing alongside the report.
• The briefing applies the underlying deal intelligence to the customer's own business, assets, technologies or partnering objectives.
• Depending on requirements, this can include relevant comparable deals, prospective partners, competitor activity, development-stage benchmarking, deal structures, financial benchmarks, contract insights and other intelligence selected specifically for the client's situation.
• Request a sample or contact Current Partnering to discuss the report and whether a customized analysis can be provided for your organization.

Table of Contents

Executive Summary

Chapter 1 - Introduction

Chapter 2 - Trends in co-development dealmaking

• 2.1. Introduction
• 2.2. Definition of co-development deal
• 2.3. Trends in co-development deals
  • 2.3.1. Co-development dealmaking by year
  • 2.3.2. Co-development dealmaking by phase of development
  • 2.3.3. Co-development dealmaking by industry sector
  • 2.3.4. Co-development dealmaking by therapy area
  • 2.3.5. Co-development dealmaking by technology type
  • 2.3.6. Co-development dealmaking by most active company
• 2.4. Reasons for entering into co-development partnering deals
• 2.5. The future of co-development deals

Chapter 3 - Overview of co-development deal structure

• 3.1. Introduction
• 3.2. Co-development agreement structure

Chapter 4 - Leading co-development deals

• 4.1. Introduction
• 4.2. Top co-development deals by value

Chapter 5 - Top 25 most active co-development dealmakers

• 5.1. Introduction
• 5.2. Top 25 most active co-development dealmakers

Chapter 6 - Co-development deals including contracts directory

• 6.1. Introduction
• 6.2. Co-development deals with contracts
• Deal directory
• Deal directory - co-development dealmaking by companies A-Z
• Deal directory - co-development dealmaking by therapy area
• Deal directory - co-development dealmaking by technology type
• About Biopharma Research
• Current Partnering
• Current Agreements
• Recent report titles from Current Partnering

TABLE OF FIGURES

• Figure 1: Definition of co-development deal
• Figure 2: Trends in co-development deal announcements
• Figure 3: Co-development deals signed at each phase of development
• Figure 4: Co-development deals by industry sector
• Figure 5: Co-development deals by therapy area
• Figure 6: Co-development deals by technology type
• Figure 7: Top 25 most active co-development dealmakers
• Figure 8: Top co-development deals by value
• Figure 9: Most active co-development dealmakers